Skip to content

National Psoriasis Foundation Forum 4(1):5, 1998

Psoriasis Forum. Additional data were obtained from the National Psoriasis Foundation website and medical textbooks. 20 Factors significantly associated with increased psoriatic arthritis risk included several markers of psoriasis severity, including earlier age at diagnosis, increased Psoriasis Area and Severity Index and Dermatology Quality of Life Index scores, increased hospitalizations for psoriasis within the last 5 years, and more workdays lost in the past 12 months. Rheum Dis Clin North Am. 1998;24(4):82944. x. 1998;28(1):417. Mark G. Lebwohl, M.D., is an American dermatologist and author and the Sol and Clara Kest Professor and Chairman of the Department of Dermatology at the Mount Sinai Hospital in New York City. He is the founding editor of Psoriasis Forum and was medical editor of the bulletin of the National Psoriasis Foundation, Psoriasis Advance. 1National Psoriasis Foundation, Portland, OR, USA. 4Association for the Care of People with Psoriasis, Rome, Italy. The organisation also raises awareness among dermatologists about PsA through its publications, including the medical journal, Psoriasis Forum.

National Psoriasis Foundation Forum 4(1):5, 1998 2The first symptom measure, the Psoriasis Symptom Assessment (PSA) scale, was adapted from the symptom scale of the validated Skindex-29 14, a measure intended to assess the effects of skin disease on the patients’ HRQL. Study B used the itch scale from the National Psoriasis Foundation score 18. 5 – 2000 Articles Volume 4 – 1999 Articles Volume 3 – 1998 Articles Volume 2 – 1996-97 Articles STL Family Practice Edition. The survey of the US National Psoriasis Foundation of 40,350 patients when over 17,000 responded. The National Psoriasis Foundation physician forum in the summer of 2002 suggested a scale by which patients could indicate improvement or worsening of their condition and specific treatments. 5 mild, 4 mild to moderate, 3 moderate, 2 moderately severe and 1 being severe psoriasis. 2009;145(1):46-51. doi:10.1001/archdermatol.2008.529. We attempted to capture a representative sample of these virtual communities by identifying 5 forum-type psoriasis support Web sites through which members could directly interact with one another: the National Psoriasis Foundation forum, the Psoriasis Help Organization, the Psoriasis Google Group, the MSN Psoriasis Group, and the Yahoo-based Psoriasis Philippines Online Community Inc. Of the 214 members of the National Psoriasis Foundation who viewed the link, 55 completed the survey, representing a 25. The mean age of the participants at 4 of the 5 sites ranged from 37 to 40 years, and most users at the same sites were female n 103 53.

2007 New Perspectives on Methotrexate and Liver Biopsies, Practical Dermatology, Vol. 4, No. 1, pg. Psoriasis is a systemic inflammatory disorder that generally comprises excessive production of skin cells leading to patches of thick, scaly, inflamed, often itchy skin. The inflammatory link between psoriasis and systemic health is underscored by reduced lifespan among those afflicted with this disease: moderate-to-severe psoriasis patients have a 5-year diminished life expectancy. According to a consensus statement issued by the National Psoriasis Foundation, patients with psoriasis represent a high-risk cardiovascular disease population. 4,5 Psoriasis treatment is costly, financially and psycologically. The National Psoriasis Foundation (NPF) was founded with the goals of providing psychosocial support and education to psoriasis patients. Table 1: Treatments for Localized Psoriasis Tar Topical corticosteroids Topical calcipotriene Topical tazarotene Anthralin (short contact therapy) Corticosteroid tape (Cordran tape) Intralesional triamcinolone For treatment purposes, we can define localized psoriasis as present when the patient is willing to apply topical therapy to all the spots (usually less that 20 body surface area). J Am Acad Dermatol 38 (6 Pt 1):1010-1011, 1998.

Validity And Reliability Of Patient Reported Outcomes Used In Psoriasis: Results From Two Randomized Clinical Trials

An open, collaborative forum could thus 1 complement more carefully vetted publications and would also be a natural dissemination pathway for registry-related work or findings produced by AHRQ and other Federal partners. Cystic Fibrosis Foundation, National Psoriasis Foundation, National Foundation for Celiac Awareness), as displayed in Figure 1. These and other features of the forum are described in more detail below, and the recommendations are summarized in Tables 2, 3, 4, and 5. 794d), as amended by the Workforce Investment Act of 1998 (P.L. 105-220), August 7, 1998. Hofer, et al, The British Journal of Dermatology 1998 Jan;138(1):96-1009. Lebwohl and Koo, National Psoriasis Foundation Forum 1997 Fall:3,624. Dermatology Foundation of South Florida Clinical Excellence Award, 2002.

Medical-clinic